These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2554039)

  • 1. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
    Uchida K; Kigoshi T; Iwasaki R; Morimoto S
    Jpn J Med; 1989; 28(4):446-51. PubMed ID: 2554039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
    Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas.
    Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Hosojima H; Uchida K; Morimoto S
    Horm Res; 1984; 19(4):224-31. PubMed ID: 6745843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
    Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
    Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary sodium on circadian rhythm and physiological responses of 18-hydroxycorticosterone.
    Sowers JR; Martin VI; Beck FW
    Clin Sci (Lond); 1983 Mar; 64(3):295-301. PubMed ID: 6295691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on plasma 18-hydroxycorticosterone and aldosterone in sodium depleted conscious rats].
    Yamamoto I; Iwasaki I; Miyauchi E; Azukizawa S; Kigoshi T; Uchida K; Morimoto S
    Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):42-9. PubMed ID: 2407571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism.
    Kigoshi T; Morimoto S; Uchida K; Hosojima H; Yamamoto I; Imaizumi N; Azukizawa S
    J Lab Clin Med; 1985 Feb; 105(2):195-200. PubMed ID: 2982980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.
    Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI
    Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of corticosteroid responses to angiotensin II in man.
    Sowers JR; Beck FW
    Clin Exp Hypertens A; 1983; 5(5):651-64. PubMed ID: 6309435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.
    Iwasaki R; Kigoshi T; Uchida K; Morimoto S
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):83-9. PubMed ID: 2545066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension.
    Semple PF; Mason PA; Fraser R
    Clin Endocrinol (Oxf); 1980 May; 12(5):473-81. PubMed ID: 7428185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
    Sowers JR; Beck FW; Waters BK; Barrett JD; Welch BG
    J Clin Endocrinol Metab; 1985 Jul; 61(1):60-7. PubMed ID: 2987296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aldosterone response to various stimuli in hyperthyroidism: in vivo and in vitro studies].
    Kigoshi T; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
    Nihon Naibunpi Gakkai Zasshi; 1993 Jun; 69(6):609-20. PubMed ID: 8396050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
    Ganguly A; Weinberger MH; Guthrie GP; Fineberg NS
    Hypertension; 1984; 6(4):563-7. PubMed ID: 6086520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus.
    Beretta-Piccoli C; Weidmann P; Fraser R
    Diabetes; 1983 Jan; 32(1):1-5. PubMed ID: 6293899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Beck FW
    J Endocrinol Invest; 1984 Oct; 7(5):473-9. PubMed ID: 6096435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Sharp B; McCallum RW
    J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.